Affordable Access

deepdyve-link
Publisher Website

Down-regulation of FOXR2 inhibits non-small cell lung cancer cell proliferation and invasion through the Wnt/β-catenin signaling pathway.

Authors
  • Wang, Xin-Hua1
  • Cui, Yan-Xiang2
  • Wang, Zhen-Min1
  • Liu, Jian3
  • 1 Department of Clinical Laboratory, Linyi City Central Hospital, Linyi, 276400, China. , (China)
  • 2 Department of Clinical Laboratory, Traditional Chinese Medical Hospital of Huangdao District, Qingdao, 266000, China. , (China)
  • 3 Department of Clinical Laboratory, Linyi City Central Hospital, Linyi, 276400, China. Electronic address: [email protected] , (China)
Type
Published Article
Journal
Biochemical and Biophysical Research Communications
Publisher
Elsevier
Publication Date
Jun 02, 2018
Volume
500
Issue
2
Pages
229–235
Identifiers
DOI: 10.1016/j.bbrc.2018.04.046
PMID: 29634928
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Forkhead box R2 (FOXR2), a new member of the FOX family, is an important player in a wide range of cellular processes such as proliferation, migration, differentiation and apoptosis. Recently, FOXR2 has been reported to be implicated in cancer development. However, the biological functions of FOXR2 in non-small cell lung cancer (NSCLC) remain unclear. In this study, we investigated the specific role of FOXR2 in NSCLC. The results showed that down-regulation of FOXR2 significantly inhibited NSCLC cell proliferation and invasion in vitro and suppressed NSCLC cell growth and metastasis in vivo. In addition, the decrease in FOXR2 expression markedly reduced the protein levels of β-catenin, cyclinD1 and c-Myc and hence inactivated the Wnt/β-catenin pathway in NSCLC cells. Taken together, we concluded that FOXR2 might be considered as a promising therapeutic target for NSCLC treatment. Copyright © 2018. Published by Elsevier Inc.

Report this publication

Statistics

Seen <100 times